Logo-bma
biomedad.ae. 2024;1(1): 34-41. doi: 10.34172/bma.06

Original Article

Impact of Allopurinol on early and one-year outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized controlled trial

Nilgoon Daviran 1 ORCID, Amirhosein Ghafouri-Asbagh 1 ORCID, Hooman Nateghian 2 * ORCID, Ahmad Separham 1 ORCID, Bahram Sohrabi 1 ORCID, Naser Aslanabadi 1 ORCID, Mehrdad Raadi 1 ORCID

Cited by CrossRef: 0



Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.